vial needle 400w

FDA Approves Xeomin® as First-Line Treatment for Focal Eye Dystonia

The US Food & Drug Administration (FDA) has approved the use of the botulinum neurotoxin Xeomin® (incobotulinumtoxinA) as a first-line treatment of blepharospasm in adults, as announced in a press release from Merz. Blepharospasm is a focal dystonia that causes muscles around the eyes to contract involuntarily. Individuals with blepharospasm may experience excessive blinking, light […]

doctor giving neck injection

Botulinum Neurotoxin Therapy Survey

We need your valuable input. Please consider participating in a brief, anonymous survey to help the Dystonia Medical Research Foundation better understand your experiences with botulinum neurotoxin injections. Individuals who are diagnosed with dystonia and receive treatment in the USA are welcome to participate. Click here to participate.  Any questions, please contact us.    

Dystonia diagnosis and x-ray

Individuals with Dystonia Needed for Brain Function Study

The Center for Neurosciences at The Feinstein Institute for Medical Research conducts one of the nation’s leading brain imaging programs directed by neuroscientist, David Eidelberg, MD. The program is internationally recognized for developing new techniques to identify and measure patterns and circuits of brain function in people with disorders such as Parkinson’s disease, Huntington’s disease, […]

doctor giving neck injection

DMRF Tackles Urgent Need for Movement Disorder Specialists

The Dystonia Medical Research Foundation (DMRF) announced Abhimanyu Mahajan, MD, MHS, University of Cincinnati, as the latest recipient of the DMRF Clinical Fellowship Award to support training in the diagnosis and treatment of movement disorders with special expertise in dystonia. Dr. Mahajan’s mentor is Alberto J. Espay, MD, MSc, Professor of Neurology, Director, James J. […]

Mahlon DeLong and Joel Perlmutter

DMRF Welcomes New Scientific Director

The DMRF is pleased to announce the appointment of Joel S. Perlmutter, MD as Scientific Director.  He is pictured (R) with Scientific Director Emeritus, Mahlon Delong, MD. Dr. Perlmutter is the Elliot H. Stein Family Professor of Neurology and Professor of Radiology, Neuroscience, Physical Therapy and Occupational Therapy; and Head of the Movement Disorders Section […]

stylized image of pill

On Target: Drug Discovery Efforts Pursue New & Improved Treatment

This article originally appeared in the Dystonia Dialogue. Drug discovery and development efforts are an important part of the Dystonia Medical Research Foundation’s (DMRF) multi-faceted science strategy. “The dystonia community cannot wait for pharmaceutical and biotech companies to necessarily get interested in dystonia on their own,” explains Jan Teller, MA, PhD, DMRF’s Chief Scientific Advisor. […]